Publications
June 17, 2024
In vitro structure–activity relationships and forensic case series of emerging 2-benzylbenzimidazole ‘nitazene’ opioids
De Vrieze LM, Walton SE, Pottie E, Papsun D, Logan BK, Krotulski AJ, Stove CP, Vandeputte MM
Archives of Toxicology
June 14, 2024
Xylazine awareness, desire, use and exposure: Preliminary findings from the Rhode Island community-based drug checking cohort study
Park JN, Serafinski R, Ujeneza M, McKenzie M, Tardif J, Krotulski AJ, Badea A, Grossman ER, Green TC
Drug and Alcohol Dependence Reports
May 23, 2024
Identification of ADB-5’Br-BINACA in plant material and analytical characterization using GC-MS, LC-QTOF-MS, NMR and ATR-FTIR
March 5, 2024
Workflow to facilitate the detection of new psychoactive substances and drugs of abuse in influent urban wastewater
Bade R, van Herwerden D, Rousis N, Adhikari S, Allen D, Baduel C, Bijlsma L, Boogaerts T, Burgard D, Chappell A, Driver EM, Sodre FF, Fatta-Kassinos D Gracia-Lor E, Gracia-Marín E, Halden RU, Heath E, Jaunay E, Krotulski A, Lai FY, ... Mueller J
Journal of Hazardous Materials
February 28, 2024
Evaluating cross-reactivity of new psychoactive substances (NPS) in human whole blood by enzyme-linked immunosorbent assay (ELISA)
February 27, 2024
Detection of xylazine in whole blood samples using high resolution mass spectrometry
February 23, 2024
Determination of fentanyl contamination on United States paper currency by LC-QQQ-MS
February 16, 2024
Wastewater-based monitoring of the nitazene analogues: First detection of protonitazene in wastewater
Bade R, Nadarajan D, Driver EM, Halden RU, Gerber C, Krotulski AJ, Hall W, Mueller JF
Science of The Total Environment
February 1, 2024
Notes from the Field: Cluster of Severe Illness from Neptune’s Fix Tianeptine Linked to Synthetic Cannabinoids — New Jersey, June–November 2023
Counts CJ, Spadaro AV, Cerbini TA, Krotulski AJ, Greller HA, Nelson LS, Ruck BE, Calello DP
Morbidity and Mortality Weekly Report (MMWR)
November 30, 2023
